A detailed history of Anchorage Capital Group, L.L.C. transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Anchorage Capital Group, L.L.C. holds 4,832,642 shares of ROIV stock, worth $55 Million. This represents 16.14% of its overall portfolio holdings.

Number of Shares
4,832,642
Previous 4,832,642 -0.0%
Holding current value
$55 Million
Previous $50.9 Million 0.28%
% of portfolio
16.14%
Previous 13.49%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022

BUY
$4.74 - $9.91 $22.9 Million - $47.9 Million
4,832,642 New
4,832,642 $23.9 Million

Others Institutions Holding ROIV

About Roivant Sciences Ltd.


  • Ticker ROIV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 704,382,976
  • Market Cap $8.02B
  • Description
  • Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...
More about ROIV
Track This Portfolio

Track Anchorage Capital Group, L.L.C. Portfolio

Follow Anchorage Capital Group, L.L.C. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Anchorage Capital Group, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Anchorage Capital Group, L.L.C. with notifications on news.